Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FOCAD antisense RNA 1 (FOCAD-AS1) is a long non-coding antisense RNA gene located on chromosome 9p21.3. As a member of the antisense IncRNA family, its function is presumed to involve regulatory effects on gene expression, potentially affecting the transcription or stability of the FOCAD gene or neighboring loci. Although antisense IncRNAs play important roles in chromatin remodeling and gene regulation—sometimes implicated in diseases such as cancer—FOCAD-AS1 itself has not yet been directly associated with any specific biological function, disease mechanism, or therapeutic application[3][4][1]. Its expression is noted to be specific within the integumentary system, but further functional characterization is lacking as of current literature[3]. No sources indicated misspelling or confusion with other similar IncRNAs (e.g., FOXP4-AS1 or other antisense IncRNAs more prominently linked to cancer)[5][8]. No evidence currently supports FOCAD-AS1 as a clinically actionable or research-validated therapeutic target[3][4].
Not applicable; no drugs are currently known to act via this target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FOCAD antisense RNA 1 (FOCAD-AS1).